Heinrich Farin

Heinrich Farin, MD has extensive work experience in the pharmaceutical and biotech industry. Heinrich currently holds the position of Senior Medical Director at AnHeart Therapeutics since August 2022. Previously, they served as Senior Medical Director at Mirati Therapeutics from August 2021 to August 2022. Prior to that, they worked as Senior Medical Director at Curis from November 2020 to March 2021 and at Flexion Therapeutics from January 2020 to October 2020.

Before joining these companies, Dr. Farin held the position of Senior Medical Director at BeiGene from August 2017 to January 2020. Heinrich also served as Medical Director, Oncology, Clinical Development, and Safety at ARIAD Pharmaceuticals, Inc. from May 2015 to May 2017.

Dr. Farin's earlier work experience includes the role of Medical Director, Hematology at Baxter BioScience from October 2009 to May 2015. Prior to that, they worked as Vice President, Clinical Development and Research Operations at Catalyst Pharmaceutical Research from 2002 to 2009 and as Director Clinical/Regulatory at Dako from 2000 to 2002.

Heinrich'scareer began at Alpha Therapeutic Corporation, where they worked as a Clinical Project Manager from 1998 to 2000.

Overall, Dr. Farin has demonstrated a consistent track record of working in leadership positions in the medical field, continually expanding their expertise and making significant contributions to various organizations.

Heinrich Farin, MD pursued their medical education at the Medical University of Vienna, where they obtained a Doctor of Medicine (MD) degree. Prior to that, they obtained Bachelor's degrees in Chemistry and Physiology from UC San Diego. Additional specific details regarding the duration of these educational pursuits are not provided.